Medicago ending its COVID-19 vaccine production in Quebec
Medicago announced on Thursday that it will be shutting down its COVID-19 vaccine project in Quebec. As a result, 586 jobs in the province will be affected. The closure comes as Medicago’s sole shareholder, the Japan-based Mitsubishi Chemical Group, decided to stop marketing the Covifenz vaccine.
UP NEXT
NOW PLAYING: newsvideos
Medicago ending its COVID-19 vaccine production in Quebec
Global NewsUP NEXT
-
More than 1 million Canadians with disabilities faced barriers while travelling in 2019, 2020: Hogan
Global News -
Winter weather holds on, postpones golf season in Manitoba
Global News -
YES Shelter in Peterborough calls on city, community members for support as homelessness crisis continues
Global News -
Family speaks out after 16-year-old boy killed at Toronto subway station
Global News -
Decision-making ‘still remains fragmented’ on Parliament’s Centre Block renovation: Hogan
Global News -
Global Affairs failing to adequately track billions in foreign aid: Hogan
Global News -
Internet access has improved, but less than 60% of access remains in rural areas and First Nations communities: Hogan
Global News -
Saskatchewan announces new critical minerals strategy to expand resource development, export
Global News -
Underused SUVs should be taxed to curb buying habits, environmental group says
Global News -
Montreal police confirm last two bodies pulled from ruins of heritage building fire
Global News -
Freeland keeps up tradition, tries on new pair of shoes ahead 2023 federal budget release
Global News -
Fire crews felt northeast Calgary explosion from station: Fire chief
Global News -
10 people in hospital, 6 in life-threatening condition after explosion in Calgary
Global News -
Teen killed in Toronto subway stabbing remembered as a kind student
Global News -
Spring break programming for kids at City of Winnipeg facilities
Global News -
Nobel Peace Prize Laureate Maria Ressa on her fight for democracy
Global News
